Efficacy and safety of vigabatrin in the long‐term treatment of refractory epilepsy.

British Journal of Clinical Pharmacology

Volumn 27, Issue 1 S, 1989, Pages 125S-129S

  Remy, C ^a   Beaumont, D ^a  

^a Centre Médical La Teppe   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID DERIVATIVE; ANTICONVULSIVE AGENT; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG RESISTANCE; EPILEPSY; EUROPE; FEMALE; HUMAN; INFANT; LIVER FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AMINOCAPROIC ACIDS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; EPILEPSY; EUROPE; FEMALE; HUMAN; INFANT; LIVER FUNCTION TESTS; MALE; MIDDLE AGE; VIGABATRIN;

EID: 0024329133     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1989.tb03473.x     Document Type: Article

References (6)

1. A study of the effects of vigabatrin on the central nervous system and retina of Sprague‐Dawley and Lister‐Hooded rats
2. Effect of vigabatrin (gamma‐vinyl‐GABA) on visual, brain stem auditory and somatosensory evoked potentials in epileptic patients
3. Effects of long‐term vigabatrin on somatosensory evoked potentials in epileptic patients
4. Meta‐analysis of European placebo controlled studies of vigabatrin in drug‐resistant epilepsy
5. Vigabatrin no microvacuoles in a human brain
6. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbemazepine, phenobarbital, phenytoin, and primidone